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AbStRACt
Ameloblastic fibroma (AF) is a rare odontogenic tumour of the jaw which usually occurs in the first 
2 decades of life. The common clinical manifestation is a slow-growing swelling. We report a case of a 
16-year-old male patient presenting with extensive AF of the mandible. He underwent a conservative 
enucleation. The tumour recurred 2 years after the initial surgery, requiring the second enucleation. 
The patient has continued to be followed closely and has been disease-free for 4 years. Recent 
evidence suggests that the recurrent rate of AF is relatively high, and malignant transformation of 
AF may occur after recurrences or multiple surgeries. A conservative treatment approach with close 
surveillance is recommended. Anatomical limitations should be taken into account, especially when 
enucleation of AF in the posterior portion of the jaw is performed. Current surgical pathologic issues 
of the tumour are also discussed. (Eur J Dent 2009;3:224-228)
Key words:   Ameloblastic fibroma; Jaw tumour; Odontogenic tumour.
Poramate Pitak-Arnnopa,b
André Chainec
Kittipong Dhanuthaid
Jacques-Charles Bertrande
Chloé Bertolusf 
Extensive Ameloblastic Fibroma in an 
Adolescent Patient: A Case Report with a 
Follow-Up of 4 Years
a  PhD candidate and resident, Department of Oral,  
  Craniomaxillofacial and Facial Plastic Surgery, 
  Faculty of Medicine, University Hospital of Leipzig,  
  Leipzig, Germany; Formerly, Department of 
  Maxillofacial Surgery, AP-HP, 
  Pitié-Salpêtrière University Hospital, 
  Faculty of Medicine, University Paris 6 (Pierre et Marie  
  Curie), Paris, France.
b  PhD candidate, Laboratory of Medical Ethics and Legal  
  Medicine, Faculty of Medicine, University Paris 5 (René  
  Descartes), Paris, France.
c  Consultant surgeon, Department of Maxillofacial  
  Surgery, AP-HP, Pitié-Salpêtrière University Hospital,  
  Faculty of Medicine, University Paris 6 (Pierre et Marie  
  Curie), Paris, France.
d  Associate Professor, Department of Oral Pathology,  
  Faculty of Dentistry, Chulalongkorn University,    
  Bangkok, Thailand.
e  Head Professor and Chairman, 
  Department of Maxillofacial Surgery, AP-HP, 
  Pitié-Salpêtrière University Hospital, 
  Faculty of Medicine, University Paris 6 (Pierre et   
  Marie Curie), Paris, France.
f  Assistant Professor, Department of Maxillofacial  
  Surgery, AP-HP, Pitié-Salpêtrière University 
  Hospital, Faculty of Medicine, University Paris 6   
  (Pierre et Marie Curie), Paris, France.
Corresponding author: Dr. Poramate Pitak-Arnnop
Klinik und Poliklinik für Mund-, Kiefer- und Plastische 
Gesichtschirurgie,
Universitätsklinikum Leipzig AöR, Nürnberger Str. 57, 
04103 Leipzig, Deutschland 
Phone: +49 341 97 21 100  
Fax: +49 341 97 21 109
E-mail: poramate.pitakarnnop@gmail.comJuly 2009 - Vol.3
225
European Journal of Dentistry
INtRoduCtIoN
Ameloblastic  fibroma  (AF)  is  an  uncommon 
odontogenic ectomesenchymal tumour of the jaw 
which is frequently seen in the first 2 decades of 
life. Its incidence is approximately 1.5-4.5% of all 
jaw tumours.1-4 AF was first described by Krause 
in  1891.5  Up  until  now,  123  patients  have  been 
reported in the English literature.2
AF  is  a  benign,  slow-growing  tumour.  Most 
of  the  cases  are  asymptomatic  and  discovered 
during  routine  oral  examination  as  a  unilocular 
radiolucent  lesion.  An  enlarging  lesion  usually 
has  a  multilocular,  radiolucent  pattern.1-3,6 
Histologically,  AF  is  consisted  of  groups  of 
an  odontogenic  epithelium  in  the  dental-
papilla  like  background  without  dental  hard 
tissue  formation.1,2,6  It  should  be  noted  that 
AF  bears  resemblance  to  various  odontogenic 
tumours,  including  ameloblastic  fibrodentinoma, 
ameloblastic fibro-odontoma, and odontoma.1-3  
Recent  evidence  suggests  that  AF  exhibits  a 
high recurrent rate and, in some cases, malignant 
transformation.2  This  finding  differs  from  the 
existing  knowledge,  arousing  more  attention  on 
this tumour. The aim of this article was to report 
a  case  of  a  16-year-old  patient  presenting  with 
extensive  AF  of  the  mandible  which  developed 
within 5 years. Clinicopathologic considerations of 
the tumour were also discussed.
CASE REPoRt
A 16-year-old white male was referred to our 
department  for  evaluation  and  management  of 
a hard, painful mass of the left cheek. He had a 
progressive swelling on this area for approximately 
4 months. His medical history was unremarkable. 
Head  and  neck  examination  revealed  no 
abnormality  other  than  a  considerable  left 
facial  swelling,  and  an  expanded  and  indurate 
mandibular buccal vestibule. On palpation of the 
left mandibular angle, cortical perforation of both 
buccal and lingual cortices, pain and tenderness 
were  found.  The  left  lower  third  molar  was 
clinically absent. All neighbouring teeth were vital 
with no evidence of other dental abnormalities. 
A panoramic radiograph showed a multilocular 
radiolucent  lesion  with  poorly-demarcated 
borders, involving the molar-ramus area of the left 
mandible. The mandibular canal was not invaded, 
but was displaced inferiorly. The left lower third 
molar was found at the inferior mandibular borders 
(Figure 1B). The patient’s panoramic film taken at 
5  years  before  this  presentation  demonstrated 
that  the  lower  left  third  molar  tooth  germ  was 
in  a  normal  position  (Figure  1A).  Computed 
tomography (CT) illustrated a voluminous, space-
occupying lesion at the posterior part of the left 
mandible. The tumour perforated both buccal and 
lingual cortices of the jaw (Figure 2).
Aspiration  biopsy  was  negative,  indicating  a 
non-cystic lesion. Histological examination of the 
incisional  biopsy  tissue  demonstrated  strands, 
cords,  and  islands  of  odontogenic  epithelium 
within  immature  myxoid  mesenchymal  tissue 
resembling  the  dental  papilla  (Figure  3).  The 
definite diagnosis was AF. 
The  patient  underwent  an  enucleation  via 
an  intra-oral  vestibular  approach  with  the 
preservation of the inferior dental nerve and the 
inferior  and  posterior  mandibular  border.  The 
impacted third molar tooth within the lesion was 
removed at the time of surgery. The immediate 
post-operative period was uneventful.
The tumour relapsed 2 years after the initial 
surgery, requiring the second enucleation (Figure 
1C).  The  patient  has  continued  to  be  followed 
closely and has been disease-free for 4 years. His 
condition has remained satisfactory, including the 
facial growth, throughout the follow-up period.
The  recommendations  of  the  Helsinki 
declaration were thoroughly maintained during the 
study. Ethical approval of this article was exempted 
by  the  Committee  of  Human  Subject  Protection 
in  Biomedical  Research  (Comité  de  Protection 
des Personnes: CPP) of Paris and its suburb, but 
the patient did not allow us to publish his clinical 
pictures.  The  national  guideline  ‘Déclaration  de 
Commission  Nationale  de  l’Informatique  et  des 
Libertés (CNIL)’ was followed in order to protect 
patient confidentiality. 
dISCuSSIoN
AF  is  an  uncommon  odontogenic  tumour. 
In  general,  it  does  not  present  with  dental 
hard  tissues.  If  the  lesion  is  similar  to  AF,  but 
contains  dentinoid  tissue  or  dentin  without  or 
with  enamel  formation,  it  should  be  designated 
under  the  names  ‘ameloblastic  fibrodentinoma’ 
(AFD)  and  ‘ameloblastic  fibroodontoma’  (AFO), 
respectively.1-3 The presentation of these different 
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tumours may be due to the degree of inductive 
changes and dental hard tissue formation of the 
same neoplastic entity (the ‘continuum’ concept). 
However, this concept has been challenged due 
to  a  number  of  reasons.  Several  longstanding, 
residual or recurrent AFs have not demonstrated 
further maturation into a more differentiated lesion 
such as AFD, AFO, or odontoma. Moreover, AFs 
are encountered at ages beyond the completion of 
odontogenesis, and some AFs occur at the higher 
age than AFO.7,8
It  is  believed  that  odontogenic  epithelium  in 
AF arises from the primordial enamel organ, and 
the stromal component originates from the dental 
papilla.9 The biological behaviour of AF shares the 
nature between harmatoma and true neoplasm. 
Clinically, this tumour is well-encapsulated and 
slow-growing.  AF  in  the  mandibular  location, 
chiefly in the posterior mandible, is more common 
than  in  the  maxillary  counterpart.  The  patients 
usually present with a hard swelling, but intra-
oral ulceration, pain, tenderness, or drainage may 
also be observed. In cases of AF in a pericoronal 
location,  the  involved  tooth  may  fail  to  erupt 
into  the  oral  cavity  (as  seen  in  our  patient). 
Radiographically,  unilocular  radiolucency  with  a 
smooth outline is associated with asymptomatic 
patients, while cases with jaw swelling generally 
have the multilocular, radiolucent pattern. Most of 
the AF lesions exhibit radiopaque borders.1-3,6 
Once  a  patient  presents  with  an  extensive 
tumour  as  seen  in  our  case,  the  differential 
diagnosis  list  should  include  ameloblastoma, 
odontogenic keratocyst and myxoma. It remains 
unknown when the tumour began in our patient. 
A  progressive  swelling  seems  to  be  only  a 
noticeable  symptom  of  an  enlarging  lesion. 
This  addresses  the  importance  of  routine  oral 
examination in childhood and adolescence which 
should be carried out thoroughly for both soft and 
Figure 1. A part of panoramic radiograph showing: A) the mandible at 5 years before the presentation of the tumour; the lower 
left third molar tooth germ was in a normal position, B) a voluminous tumour involving the molar-ramus area of the left mandible 
and displacement of the left lower third molar (yellow arrow), and C) the recurrent tumour at the left mandibular ramus (green 
arrow).
Figure 2. Non-contrast axial CT at bone algorithm showing an 
expansive,  homogeneously  hypoattenuated  mass  occupying 
the  posterior  part  of  the  left  mandible.  Buccal  and  lingual 
cortical perforation was evident (red arrow).
Figure  3.  Photomicrograph  showing  cords  and  islands  of 
odontogenic  epithelium  in  a  primitive  connective  tissue 
background resembling a dental papilla without the formation 
of dental hard tissues (Haematoxylin & eosin stain, original 
magnification 40x).
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hard  tissues  of  the  oral  cavity.  Had  the  patient 
undergone  routine  check-up,  the  lesion  would 
have been detected earlier before it developed into 
a voluminous size.
Microscopically,  AF  comprises  strands  and 
islands of an odontogenic epithelium in a loose 
and  primitive  connective  tissue  stroma  which 
is  characteristic  of  dental  papilla  (embryonic 
dental pulp). The odontogenic epithelial cells are 
similar to those of ameloblastoma. Tiny islands 
resembling the follicular stage of the developing 
enamel  organ  may  be  observed.1,2,6  Some 
recurrent cases developed dentin formation with 
or without enamel structures, and subsequently 
differentiate over time into odontoma. Of particular 
note, AF in young populations may resemble the 
primitive  stage  of  odontoma.2  In  cases  undergo 
malignant  transformation,  there  is  unequivocal 
changes in the mesenchymal component, and the 
odontogenic epithelium is completely disappeared. 
The  diagnosis  of  malignant  transformation  of 
AF is established by tracing back the primary or 
recurrent lesions in which typical features of AF 
could be recognised.2,3
The  hybrid  tumour  between  calcified 
odontogenic cyst (COC; Gorlin’s cyst) and AF has 
been reported in the literature. Care must be taken 
to differentiate this mixed tumour from either AFO 
or AFD. The aetiology of the coexistence remains 
unclear. It is possible that odontogenic epithelium 
of  COC  induces  the  surrounding  mesenchymal 
tissues to develop the other separate lesion.10,11 
However,  Altini  and  Farman12  suggested  that 
cystic degeneration of AF caused the development 
of the COC component. This collision phenomenon 
may also occur with other cystic lesions, such as 
dentigerous cyst or unicystic ameloblastoma.13
The  name  of  AF  indicates  a  non-aggressive 
behaviour. However, a large series of AF revealed 
that its recurrent rate at 10 years after operation 
was approximately 70%.2 Malignant transformation 
of AF has been reported sporadically in recurrent 
AF or after multiple surgeries.3,7,14,15 Chen et al2 
found that 14 of 41 recurrent AF cases developed 
malignant  changes,  and  the  estimated  10-year 
malignant  transformation  rate  was  one-fourth 
of the cases. Patient age at the presentation (> 
22 years old) was found to be the only potential 
risk  of  malignant  AF.2  Therefore,  based  on 
evidence at present, close and long-term follow-
up is indeed crucial. Special care should be taken 
in  recurrent  cases  with  regard  to  malignant 
transformation.  However,  these  data  must  be 
interpreted  with  caution  because  malignant 
transformation of a benign tumour may be easily 
and frequently accepted for publication (so-called 
‘publication bias’), resulting in an exaggerated and 
overestimated incidence.
Malignant  transformation  of  AF  was  found 
to  be  associated  with  oncogenic  aberrations 
in  tumour-related  genes.9  Mesenchymal 
proliferation within the tumour resulting in a loss 
of an epithelial component, is a usual presentation 
of  sarcomatous  changes  of  AF.2  Hence,  the 
histological  distinction  between  ameloblastic 
fibrosarcoma  arising  from  pre-existing  AF  and 
conventional  (true)  ameloblastic  fibrosarcoma 
seems  to  be  difficult.  Reviewing  the  previous 
histopathological slides when the tumour recurs 
is  beneficial.3,14,15  If  malignant  changes  occur 
in  both  epithelial  and  stromal  components,  the 
tumour is dubbed ‘ameloblastic carcinosarcoma’.7 
Regional lymphadenopathy and distant metastasis 
is infrequent in the vast majority of AF cases with 
malignant transformation.2 
Management  of  AF  varies  between  reports. 
In  general,  a  conservative  approach,  such  as 
enucleation  with  curettage  of  the  surrounding 
bone,  should  be  applied  for  young  patients. 
Conversely, an extensive tumour and/or multiple 
recurrences necessitate more radical therapies. 
Recurrence  commonly  results  from  incomplete 
removal of the tumour.1-3 The recurrence in our 
patient may be due to a residual tumour following 
the conservative surgery. Limited surgical access 
in  the  posterior  mandibular  region  complicates 
complete tumour removal. 
CT  scan  is  of  clinical  value  during  both  the 
treatment  planning  and  the  surveillance  of 
recurrence.  Some  authors  suggested  the  use 
of  proliferating  indices,  such  as  AgNOR,  PCNA 
and Ki-67, to institute an appropriate treatment 
for  each  patient,  and  possibly,  to  suggest  the 
malignant development.2,15 However, there is still 
little  evidence  supporting  this  notion;  thereby, 
more investigations are still warranted. 
CoNCLuSIoNS
The  patient  reported  here  presented  an 
uncommon  feature  of  AF:  a  voluminous  lesion 
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occupying the posterior portion of the mandible. 
However, he was relatively young at the time of 
presentation.  We,  therefore,  decided  to  apply 
a  conservative  approach  and  a  ‘wait  and  see’ 
protocol for this patient. 
Because  of  its  high  recurrent  rate  and  a 
possibility of malignant transformation, the term 
‘benign tumour’ in case of AF should not falsely 
impart  a  simultaneous  designation  of  ‘non-
aggressive’. Complete excision with close follow-
up is highly recommended.
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